![Cardiovascular Risks of Nonsteroidal Antiinflammatory Drugs in Patients After Hospitalization for Serious Coronary Heart Disease | Circulation: Cardiovascular Quality and Outcomes Cardiovascular Risks of Nonsteroidal Antiinflammatory Drugs in Patients After Hospitalization for Serious Coronary Heart Disease | Circulation: Cardiovascular Quality and Outcomes](https://www.ahajournals.org/cms/asset/1a7cace3-4767-4dd0-a86c-7886e9c80050/6ff1.jpeg)
Cardiovascular Risks of Nonsteroidal Antiinflammatory Drugs in Patients After Hospitalization for Serious Coronary Heart Disease | Circulation: Cardiovascular Quality and Outcomes
![Are prescribers not aware of cardiovascular contraindications for diclofenac? A claims data analysis - Scholle - 2020 - Journal of Internal Medicine - Wiley Online Library Are prescribers not aware of cardiovascular contraindications for diclofenac? A claims data analysis - Scholle - 2020 - Journal of Internal Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/ba759d38-2191-43ae-a34a-a95dc3c2ba19/joim12990-toc-0001-m.jpg)
Are prescribers not aware of cardiovascular contraindications for diclofenac? A claims data analysis - Scholle - 2020 - Journal of Internal Medicine - Wiley Online Library
![Cancers | Free Full-Text | Development and Challenges of Diclofenac-Based Novel Therapeutics: Targeting Cancer and Complex Diseases Cancers | Free Full-Text | Development and Challenges of Diclofenac-Based Novel Therapeutics: Targeting Cancer and Complex Diseases](https://www.mdpi.com/cancers/cancers-14-04385/article_deploy/html/images/cancers-14-04385-g001.png)
Cancers | Free Full-Text | Development and Challenges of Diclofenac-Based Novel Therapeutics: Targeting Cancer and Complex Diseases
![Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison - The Lancet Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison - The Lancet](https://www.thelancet.com/cms/attachment/2000988127/2003634384/gr1.gif)
Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison - The Lancet
![PDF) Are prescribers not aware of cardiovascular contraindications for diclofenac? A claims data analysis PDF) Are prescribers not aware of cardiovascular contraindications for diclofenac? A claims data analysis](https://i1.rgstatic.net/publication/337188264_Are_prescribers_not_aware_of_cardiovascular_contraindications_for_diclofenac_A_claims_data_analysis/links/5dcaa56aa6fdcc5750424b08/largepreview.png)
PDF) Are prescribers not aware of cardiovascular contraindications for diclofenac? A claims data analysis
![Painkillers warning: Millions told not to take pills linked to heart attacks and strokes | Daily Mail Online Painkillers warning: Millions told not to take pills linked to heart attacks and strokes | Daily Mail Online](https://i.dailymail.co.uk/i/pix/2013/06/29/article-2351477-1A918FC7000005DC-496_634x346.jpg)
Painkillers warning: Millions told not to take pills linked to heart attacks and strokes | Daily Mail Online
![ESC: Ibuprofen and diclofenac linked with heart failure in patients with type 2 diabetes - Pavilion Health Today ESC: Ibuprofen and diclofenac linked with heart failure in patients with type 2 diabetes - Pavilion Health Today](https://pavilionhealthtoday.com/wp-content/uploads/2022/09/tablet-oral-antiviral-primary.jpg)
ESC: Ibuprofen and diclofenac linked with heart failure in patients with type 2 diabetes - Pavilion Health Today
![Comparative evaluation of cardiovascular outcomes in patients with osteoarthritis and rheumatoid arthritis on recommended doses of nonsteroidal anti-inflammatory drugs | Semantic Scholar Comparative evaluation of cardiovascular outcomes in patients with osteoarthritis and rheumatoid arthritis on recommended doses of nonsteroidal anti-inflammatory drugs | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/cbe81173d49e1a76647abfd011d795f33b6f113d/7-Table6-1.png)
Comparative evaluation of cardiovascular outcomes in patients with osteoarthritis and rheumatoid arthritis on recommended doses of nonsteroidal anti-inflammatory drugs | Semantic Scholar
![Non-steroidal anti-inflammatory drugs and risk of heart failure in four European countries - UCLA-Olive View Internal Medicine Non-steroidal anti-inflammatory drugs and risk of heart failure in four European countries - UCLA-Olive View Internal Medicine](https://www.oliveviewim.org/wp-content/uploads/2017/10/NSAIDS-and-heart-failure-figure1-truncated.png)